Cargando…
Progression of Gastrointestinal Injury During Antiplatelet Therapy After Percutaneous Coronary Intervention: A Secondary Analysis of the OPT-PEACE Randomized Clinical Trial
IMPORTANCE: Gastrointestinal injury progression induced by antiplatelet therapy in patients after percutaneous coronary intervention (PCI) has not been well studied. OBJECTIVE: To assess the association of aspirin, clopidogrel, and their combination with gastrointestinal injury progression among pat...
Autores principales: | He, Chen, Li, Yi, Jiang, Xi, Jiang, Meng-Ni, Zhao, Xian-Xian, Ma, Shu-Ren, Bao, Dan, Qiu, Miao-Han, Deng, Jie, Wang, Jin-Hai, Qu, Peng, Jiang, Chun-Meng, Jia, Shao-Bin, Yang, Shao-Qi, Ru, Lei-Sheng, Feng, Jia, Gao, Wei, Huang, Yong-Hui, Tao, Ling, Han, Ying, Yang, Kan, Wang, Xiao-Yan, Zhang, Wen-Juan, Wang, Bang-Mao, Li, Yue, Yang, You-Lin, Li, Jun-Xia, Sheng, Jian-Qiu, Ma, Yi-Tong, Cui, Min, Ma, Si-Cong, Wang, Xiao-Zeng, Li, Zhao-Shen, Liao, Zhuan, Han, Ya-Lin, Stone, Gregg W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656648/ https://www.ncbi.nlm.nih.gov/pubmed/37976067 http://dx.doi.org/10.1001/jamanetworkopen.2023.43219 |
Ejemplares similares
-
Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial
por: Li, Yi, et al.
Publicado: (2020) -
Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study
por: Na, Kun, et al.
Publicado: (2023) -
Time of Resumption of Antiplatelet Drugs After Upper Gastrointestinal Hemorrhage
por: Ma, Huan, et al.
Publicado: (2022) -
Clinical Presentations, Antiplatelet Strategies and Prognosis of Patients with Stent Thrombosis: An Observational Study of 140 Patients
por: Han, Ya-Ling, et al.
Publicado: (2012) -
Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-κB/miR-155-5p inflammatory loop
por: Zhou, Yang, et al.
Publicado: (2021)